Maastricht University-ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2016

  1. Bilastine: A new antihistamine with an optimal benefit-to-risk ratio for safety during driving

    Expert Opinion on Drug Safety, Vol. 15, Núm. 1, pp. 89-98

2014

  1. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 2, pp. 175-185